Subclinical Atrial Fibrillation and the Risk of Stroke
Jeff S. Healey(Population Health Research Institute), Stefan H. Hohnloser(Goethe University Frankfurt), Michael R. Gold(Medical University of South Carolina), Sean Yang(Population Health Research Institute), Alessandro Capucci(Marche Polytechnic University), Ellison Themeles(Population Health Research Institute), Carsten W. Israel(Evangelisches Krankenhaus Bielefeld), Stuart J. Connolly(Population Health Research Institute), Carlos A. Morillo(Spanish National Centre for Cardiovascular Research), Christophe Bailleul(St. Jude Medical Center), Eric Fain(St. Jude Medical Center), C.P. Lau(Queen Mary Hospital), Elizabeth S. Kaufman(MetroHealth Medical Center), Mark D. Carlson(Kent Hospital), Isabelle C. Van Gelder(University Medical Center Groningen)
Cited by 2,077
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
|New England Journal of Medicine|2010|1.8k
Canadian Implantable Defibrillator Study (CIDS)
|Circulation|2000|1.6k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k